Aurora Cannabis Inc.(ACB)Earnings, Financials & Key Ratios
ACB•NASDAQ
$3.54
$201M mkt cap·168.8× P/E·Price updated May 6, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryCannabis and cannabinoid product companies
AboutAurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.Show more
- Revenue$343M+27.0%
- EBITDA$27M+305.5%
- Net Income$2M+102.3%
- EPS (Diluted)0.03+102.2%
- Gross Margin54.65%+12.4%
- EBITDA Margin8.01%+261.8%
- Operating Margin1.44%+108.4%
- Net Margin0.46%+101.8%
- ROE0.26%+102.1%
- ROIC0.71%+109.9%
- Debt/Equity0.17+3.8%
- Interest Coverage0.59+117.9%
ACB Key Insights
Aurora Cannabis Inc. (ACB) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 7/9
- ✓High quality earnings: Operating CF exceeds net income
- ✓Trading at only 0.4x book value
✗Weaknesses
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 19 (bottom 19%)
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
ACB Price & Volume
Aurora Cannabis Inc. (ACB) stock price & volume — 10-year historical chart
Loading chart...
ACB Growth Metrics
Aurora Cannabis Inc. (ACB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years5.02%
3 Years15.75%
TTM12.79%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM364.44%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-829.65%
Return on Capital
10 Years-15.36%
5 Years-12.17%
3 Years-12.01%
Last Year0.68%
ACB Recent Earnings
Aurora Cannabis Inc. (ACB) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 4/12 qtrs (36%)
Q1 2026Latest
Feb 4, 2026EPS
$0.09
Est $0.10
-7.4%
Revenue
$69M
Est $67M
+2.0%
Q4 2025
Nov 5, 2025EPS
$0.09
Est $0.03
+200.0%
Revenue
$63M
Est $88M
-28.4%
Q3 2025
Aug 6, 2025EPS
$0.19
Est $0.18
-205.6%
Revenue
$65M
Est $94M
-30.9%
Q3 2025
Jun 18, 2025EPS
$0.07
Est $0.11
-36.4%
Revenue
$63M
Est $89M
-28.8%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 4, 2026 | $0.09vs $0.10-7.4% | $69Mvs $67M+2.0% |
| Q4 2025 | Nov 5, 2025 | $0.09vs $0.03+200.0% | $63Mvs $88M-28.4% |
| Q3 2025 | Aug 6, 2025 | $0.19vs $0.18-205.6% | $65Mvs $94M-30.9% |
| Q3 2025 | Jun 18, 2025 | $0.07vs $0.11-36.4% | $63Mvs $89M-28.8% |
Based on last 12 quarters of dataView full earnings history →
ACB Peer Comparison
Aurora Cannabis Inc. (ACB) competitors in Cannabis and cannabinoid product companies — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CGC | 123.69M | 1.15 | -0.28 | -9.47% | -110.99% | -43.07% | 0.72 | |
 TLRY | 671.17M | 5.76 | -0.17 | 4.84% | -252.55% | -136.55% | 0.22 | |
 CRON | 999.77M | 2.62 | 64.4% | -4.89% | -0.86% | 0.00 | ||
 OGI | 187.84M | 1.39 | -13.49 | 16.42% | 6.48% | 4.92% | 0.03 | |
 SMG | 3.65B | 62.85 | 25.45 | -3.93% | 2.68% | |||
 IIPR | 1.65B | 57.69 | 14.68 | -13.8% | 45.58% | 6.41% | 0.21 | |
 HYFM | 5.32M | 1.14 | -0.08 | -16.02% | -44.49% | -32.29% | 0.76 | |
 LWAY | 405.93M | 26.65 | 29.94 | 13.74% | 6.52% | 17.25% | 0.00 |
Compare ACB vs Peers
Aurora Cannabis Inc. (ACB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ACB Income Statement
Aurora Cannabis Inc. (ACB) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Mar'23 | Mar'24 | Mar'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 18.07M | 55.2M | 245.54M | 268.7M | 245.25M | 221.34M | 223.8M | 270.28M | 343.29M | 361.13M |
| Revenue Growth % | 1155.52% | 205.51% | 344.84% | 9.44% | -8.73% | -9.75% | 1.11% | 20.77% | 27.01% | 12.79% |
| Cost of Goods Sold | 2.01M | 11.68M | 103.1M | 288.64M | 266.81M | 200.11M | 209.02M | 138.82M | 155.69M | 134.61M |
| COGS % of Revenue | 11.13% | 21.16% | 41.99% | 107.42% | 108.79% | 90.41% | 93.39% | 51.36% | 45.35% | - |
| Gross Profit | 16.06M▲ 0% | 43.52M▲ 171.0% | 142.44M▲ 227.3% | -19.93M▼ 114.0% | -21.56M▼ 8.1% | 21.23M▲ 198.5% | 14.78M▼ 30.3% | 131.46M▲ 789.2% | 187.61M▲ 42.7% | 226.51M▲ 0% |
| Gross Margin % | 88.87% | 78.84% | 58.01% | -7.42% | -8.79% | 9.59% | 6.61% | 48.64% | 54.65% | 62.72% |
| Gross Profit Growth % | 629.16% | 171.05% | 227.31% | -114% | -8.14% | 198.46% | -30.35% | 789.2% | 42.71% | - |
| Operating Expenses | 27.25M | 139.29M | 460.72M | 445.85M | 261.26M | 252.67M | 221.98M | 177.91M | 182.66M | 178.39M |
| OpEx % of Revenue | 150.82% | 252.36% | 187.64% | 165.93% | 106.53% | 114.16% | 99.18% | 65.83% | 53.21% | - |
| Selling, General & Admin | 24.67M | 109.86M | 365.38M | 345.75M | 194.88M | 188.99M | 170.47M | 156.88M | 166.47M | 165.36M |
| SG&A % of Revenue | 136.53% | 199.04% | 148.81% | 128.67% | 79.46% | 85.39% | 76.17% | 58.04% | 48.49% | - |
| Research & Development | 314K | 1.68M | 14.78M | 26.03M | 11.45M | 10.39M | 5.77M | 3.57M | 3.68M | 3.95M |
| R&D % of Revenue | 1.74% | 3.04% | 6.02% | 9.69% | 4.67% | 4.69% | 2.58% | 1.32% | 1.07% | - |
| Other Operating Expenses | 2.27M | 27.75M | 80.56M | 74.07M | 54.94M | 53.29M | 45.73M | 17.46M | 12.52M | 3M |
| Operating Income | -11.19M▲ 0% | -95.77M▼ 755.7% | -318.28M▼ 232.3% | -465.78M▼ 46.3% | -282.82M▲ 39.3% | -231.45M▲ 18.2% | -207.19M▲ 10.5% | -46.45M▲ 77.6% | 4.95M▲ 110.7% | 48.13M▲ 0% |
| Operating Margin % | -61.95% | -173.51% | -129.63% | -173.34% | -115.32% | -104.57% | -92.58% | -17.19% | 1.44% | 13.33% |
| Operating Income Growth % | -143.83% | -755.72% | -232.33% | -46.34% | 39.28% | 18.16% | 10.48% | 77.58% | 110.65% | - |
| EBITDA | -10.11M | -83.51M | -230.02M | -351.06M | -184.74M | -137.79M | -154.6M | -13.38M | 27.5M | 71.33M |
| EBITDA Margin % | -55.93% | -151.3% | -93.68% | -130.65% | -75.33% | -62.25% | -69.08% | -4.95% | 8.01% | 19.75% |
| EBITDA Growth % | -152.81% | -726.44% | -175.44% | -52.62% | 47.38% | 25.42% | -12.2% | 91.34% | 305.46% | 15.09% |
| D&A (Non-Cash Add-back) | 1.09M | 12.26M | 88.25M | 114.72M | 98.08M | 93.66M | 52.59M | 33.07M | 22.55M | 23.2M |
| EBIT | -15.97M | 89.09M | -291.24M | -3.26B | -633.36M | -1.65B | -187.59M | -45.41M | 28.8M | 52.82M |
| Net Interest Income | -5.72M | -9.25M | -35.73M | -70.2M | -60.69M | -67.31M | -20.46M | -1.37M | 3.08M | -279K |
| Interest Income | 861K | 2.52M | 3.68M | 5.91M | 5.75M | 4.51M | 19M | 12.81M | 11.51M | 8.15M |
| Interest Expense | 1.29M | 11.76M | 39.41M | 76.11M | 66.44M | 71.81M | 39.46M | 14.19M | 8.42M | 8.43M |
| Other Income/Expense | -6.07M | 173.1M | -12.37M | -2.87B | -416.98M | -1.49B | -576.51M | -13.15M | 15.43M | -5.56M |
| Pretax Income | -17.26M▲ 0% | 77.33M▲ 547.9% | -330.65M▼ 527.6% | -3.34B▼ 910.1% | -699.8M▲ 79.0% | -1.72B▼ 145.8% | -783.7M▲ 54.4% | -59.6M▲ 92.4% | 20.38M▲ 134.2% | 42.57M▲ 0% |
| Pretax Margin % | -95.56% | 140.1% | -134.66% | -1242.91% | -285.34% | -777.14% | -350.17% | -22.05% | 5.94% | 11.79% |
| Income Tax | -4.3M | 8.1M | -29.91M | -82.23M | -6.32M | -2.14M | 16.55M | -554K | 4.62M | 3.84M |
| Effective Tax Rate % | 24.88% | 10.47% | 9.05% | 2.46% | 0.9% | 0.12% | -2.11% | 0.93% | 22.66% | 9.02% |
| Net Income | -12.97M▲ 0% | 71.94M▲ 654.7% | -293.51M▼ 508.0% | -3.28B▼ 1018.4% | -693.63M▲ 78.9% | -1.72B▼ 147.6% | -816.63M▲ 52.5% | -69.33M▲ 91.5% | 1.59M▲ 102.3% | 40.6M▲ 0% |
| Net Margin % | -71.78% | 130.33% | -119.54% | -1221.68% | -282.82% | -776.02% | -364.88% | -25.65% | 0.46% | 11.24% |
| Net Income Growth % | -126.59% | 654.72% | -508.01% | -1018.43% | 78.87% | -147.63% | 52.46% | 91.51% | 102.3% | 364.44% |
| Net Income (Continuing) | -12.97M | 69.23M | -300.74M | -3.26B | -693.48M | -1.72B | -800.25M | -59.05M | 15.76M | 38.73M |
| Discontinued Operations | 0 | 0 | 144K | -51.86M | -1.61M | 0 | -23.66M | -10.28M | -14.17M | 119K |
| Minority Interest | 0 | 4.59M | 4.43M | -24.25M | 0 | 31.06M | 31.06M | 42.17M | 41.18M | 31.47M |
| EPS (Diluted) | -6.00▲ 0% | 18.00▲ 400.0% | -36.65▼ 303.6% | -333.92▼ 811.1% | -40.92▲ 87.7% | -79.92▼ 95.3% | -8.17▲ 89.8% | -1.28▲ 84.3% | 0.03▲ 102.2% | 0.71▲ 0% |
| EPS Growth % | -12.78% | 400% | -303.61% | -811.11% | 87.75% | -95.31% | 89.78% | 84.33% | 102.23% | -829.65% |
| EPS (Basic) | -5.58 | 18.77 | -36.65 | -333.92 | -40.92 | -79.92 | -8.17 | -1.28 | 0.03 | - |
| Diluted Shares Outstanding | 2.33M | 3.93M | 8.01M | 9.68M | 16.91M | 21.49M | 32.27M | 51.26M | 55.75M | 57.32M |
| Basic Shares Outstanding | 2.16M | 4M | 8.01M | 9.83M | 16.95M | 21.49M | 32.27M | 51.26M | 54.88M | 56.7M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
ACB Balance Sheet
Aurora Cannabis Inc. (ACB) balance sheet — assets, liabilities & shareholders' equity
| Line item | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Mar'23 | Mar'24 | Mar'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 194.29M | 221.2M | 663.1M | 415.75M | 665.05M | 479.96M | 479.96M | 427.35M | 475.58M | 445.84M |
| Cash & Short-Term Investments | 175.26M | 150.4M | 363.42M | 168.53M | 444.04M | 300.86M | 300.86M | 183.58M | 184.81M | 108.45M |
| Cash Only | 160.28M | 90.8M | 219.63M | 161.49M | 440.3M | 300.86M | 300.86M | 179.53M | 184.26M | 56.36M |
| Short-Term Investments | 14.98M | 59.59M | 143.8M | 7.04M | 3.75M | 0 | 0 | 4.04M | 550.82K | 52.09M |
| Accounts Receivable | 2.32M | 15.2M | 112.76M | 53.88M | 56.19M | 41.35M | 41.35M | 45.49M | 42.23M | 44.19M |
| Days Sales Outstanding | 46.87 | 100.51 | 167.62 | 73.19 | 83.63 | 68.18 | 67.43 | 61.43 | 44.9 | 43.58 |
| Inventory | 11.83M | 43.51M | 162.51M | 153.39M | 137.55M | 128.83M | 128.83M | 186.7M | 237.72M | 230.56M |
| Days Inventory Outstanding | 2.15K | 1.36K | 575.34 | 193.97 | 188.17 | 234.98 | 224.97 | 490.89 | 557.32 | 623.38 |
| Other Current Assets | 3.37M | 12.1M | 24.42M | 39.95M | 27.27M | 8.92M | 8.92M | 11.58M | 10.82M | 47.72M |
| Total Non-Current Assets | 129.53M | 1.68B | 4.97B | 2.5B | 2.06B | 446.42M | 446.42M | 412.79M | 372.19M | 329.46M |
| Property, Plant & Equipment | 45.68M | 248.04M | 768.49M | 942.39M | 605.33M | 322.99M | 322.99M | 294.84M | 266.57M | 259.11M |
| Fixed Asset Turnover | 0.40x | 0.22x | 0.32x | 0.29x | 0.41x | 0.69x | 0.69x | 0.92x | 1.29x | 1.37x |
| Goodwill | 41.25M | 765.96M | 3.18B | 923.97M | 886.62M | 18.72M | 18.72M | 43.26M | 43.62M | 25.64M |
| Intangible Assets | 31.2M | 201.71M | 691M | 410.53M | 366.99M | 59.68M | 59.68M | 40.92M | 44.9M | 35.66M |
| Long-Term Investments | 11.4M | 462.53M | 206.04M | 63.28M | 73.93M | 13.75M | 13.75M | 6.35M | 5.23M | 18.68M |
| Other Non-Current Assets | 0 | 0 | 6.95M | 12.28M | 3.53M | 15.79M | 15.79M | 12.05M | 7.68M | 24.83M |
| Total Assets | 323.82M▲ 0% | 1.9B▲ 486.6% | 5.64B▲ 196.8% | 2.92B▼ 48.3% | 2.72B▼ 6.7% | 926.38M▼ 66.0% | 926.38M▲ 0.0% | 840.14M▼ 9.3% | 847.77M▲ 0.9% | 775.29M▲ 0% |
| Asset Turnover | 0.06x | 0.03x | 0.04x | 0.09x | 0.09x | 0.24x | 0.24x | 0.32x | 0.40x | 0.45x |
| Asset Growth % | 1667.72% | 486.57% | 196.82% | -48.26% | -6.71% | -65.96% | 0% | -9.31% | 0.91% | -15.37% |
| Total Current Liabilities | 23.55M | 75.68M | 438.03M | 271.11M | 116.23M | 237.75M | 237.75M | 124.84M | 110.23M | 145.94M |
| Accounts Payable | 8.78M | 47.78M | 38.82M | 19.62M | 13.26M | 21.94M | 21.94M | 20.36M | 27.46M | 67.97M |
| Days Payables Outstanding | 1.59K | 1.49K | 137.43 | 24.81 | 18.14 | 40.02 | 38.32 | 53.53 | 64.38 | 153.51 |
| Short-Term Debt | 69.24K | 2.47M | 250.62M | 151.97M | 40.89M | 147.56M | 147.56M | 57.32M | 26.74M | 61.77M |
| Deferred Revenue (Current) | 1.43M | 2.28M | 1.48M | 3.49M | 4.16M | 1.74M | 1.74M | 1.69M | 1.07M | 4.2M |
| Other Current Liabilities | 13.27M | 21.48M | 129.32M | 72.37M | 48.68M | 53.73M | 53.73M | 28.4M | 27.87M | 3.25M |
| Current Ratio | 8.25x | 2.92x | 1.51x | 1.53x | 5.72x | 2.02x | 2.02x | 3.42x | 4.31x | 4.31x |
| Quick Ratio | 7.75x | 2.35x | 1.14x | 0.97x | 4.54x | 1.48x | 1.48x | 1.93x | 2.16x | 2.16x |
| Cash Conversion Cycle | 600.23 | -32.96 | 605.52 | 242.34 | 253.65 | 263.14 | 254.08 | 498.79 | 537.84 | 513.45 |
| Total Non-Current Liabilities | 80.57M | 260.19M | 795.74M | 531.45M | 569.74M | 166.89M | 166.89M | 112.38M | 132.45M | 61.53M |
| Long-Term Debt | 63.76M | 202.14M | 396.67M | 293.68M | 292.81M | 36.17M | 36.17M | 4.91M | 39.96M | 0 |
| Capital Lease Obligations | 283K | 0 | 0 | 83.35M | 65.35M | 42.68M | 42.68M | 37.56M | 37.28M | 141.95M |
| Deferred Tax Liabilities | 5.96M | 55.78M | 208.97M | 152.56M | 119.65M | 16.75M | 16.75M | 16.22M | 1.89M | 10.77M |
| Other Non-Current Liabilities | 0 | 0 | 190.1M | 1.86M | 91.93M | 71.3M | 71.3M | 53.69M | 53.32M | 126.47M |
| Total Liabilities | 104.11M | 335.87M | 1.23B | 802.56M | 685.97M | 404.64M | 404.64M | 237.22M | 242.67M | 207.47M |
| Total Debt | 64.11M | 204.6M | 647.29M | 529.01M | 399.05M | 226.41M | 226.41M | 99.78M | 103.98M | 100.99M |
| Net Debt | -96.17M | 113.8M | 427.66M | 367.51M | -41.25M | -74.45M | -74.45M | -79.75M | -80.28M | 31.82M |
| Debt / Equity | 0.29x | 0.13x | 0.15x | 0.25x | 0.20x | 0.43x | 0.43x | 0.17x | 0.17x | 0.17x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | 3.78x | 1.42x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | -2.92x | -2.92x |
| Interest Coverage | -8.66x | -8.14x | -8.08x | -6.12x | -4.26x | -3.22x | -5.25x | -3.27x | 0.59x | 6.27x |
| Total Equity | 219.71M▲ 0% | 1.56B▲ 611.7% | 4.4B▲ 181.7% | 2.11B▼ 52.0% | 2.04B▼ 3.7% | 521.74M▼ 74.4% | 521.74M▲ 0.0% | 602.92M▲ 15.6% | 605.09M▲ 0.4% | 567.83M▲ 0% |
| Equity Growth % | 3728.85% | 611.66% | 181.67% | -51.99% | -3.74% | -74.36% | 0% | 15.56% | 0.36% | -11.14% |
| Book Value per Share | 94.49 | 398.08 | 549.67 | 218.52 | 120.34 | 24.28 | 16.17 | 11.76 | 10.85 | 9.91 |
| Total Shareholders' Equity | 219.71M | 1.56B | 4.4B | 2.14B | 2.04B | 490.67M | 490.67M | 560.75M | 563.91M | 536.36M |
| Common Stock | 222.23M | 1.48B | 4.69B | 5.76B | 6.42B | 6.84B | 6.84B | 6.98B | 6.95B | 7B |
| Retained Earnings | -28.53M | 88.35M | -287.41M | -3.58B | -4.32B | -6.29B | -6.29B | -6.38B | -6.33B | -6.4B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 26M | -5.86M | -3.5M | -41.63M | -65.43M | -58.33M | -58.33M | -43.78M | -55.91M | -215.03M |
| Minority Interest | 0 | 4.59M | 4.43M | -24.25M | 0 | 31.06M | 31.06M | 42.17M | 41.18M | 31.47M |
ACB Cash Flow Statement
Aurora Cannabis Inc. (ACB) cash flow — operating, investing & free cash flow history
| Line item | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Mar'23 | Mar'24 | Mar'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -13.38M | -81.67M | -192.25M | -342.14M | -210.58M | -110.27M | -115.82M | -68.51M | 16M | 16M |
| Operating CF Margin % | -74.05% | -147.96% | -78.3% | -127.33% | -85.86% | -49.82% | -51.75% | -25.35% | 4.66% | - |
| Operating CF Growth % | -97.55% | -510.46% | -135.4% | -77.97% | 38.45% | 47.64% | -5.04% | 40.85% | 123.36% | 34.91% |
| Net Income | -12.97M | 69.23M | -300.74M | -3.26B | -693.48M | -1.72B | -265.33M | -59.05M | 15.76M | 40.6M |
| Depreciation & Amortization | 1.09M | 12.26M | 88.25M | 114.72M | 98.08M | 93.66M | 43.57M | 33.07M | 22.55M | 24.76M |
| Stock-Based Compensation | 7.58M | 37.45M | 107.04M | 59.18M | 20.24M | 13.76M | 16.89M | 12.72M | 11.52M | 6.8M |
| Deferred Taxes | -4.28M | 6.44M | -23.91M | -77.14M | -6.44M | -2.19M | -18.4M | -1.67M | -3.19M | 2.46M |
| Other Non-Cash Items | -2.35M | -181.65M | -25.61M | 2.81B | 370.63M | 1.45B | 190.11M | -37.96M | -40.85M | 44.12M |
| Working Capital Changes | -2.46M | -25.39M | -37.28M | 7.59M | 397K | 52.65M | -25.12M | -15.63M | 10.21M | 321.1K |
| Change in Receivables | -1.62M | -12.36M | -68.52M | 55.16M | 7.37M | 18.34M | 5.53M | -4.33M | 5.24M | -6.3M |
| Change in Inventory | -1.68M | -8.99M | -50.42M | -26.32M | 8.45M | 21.07M | 49.03M | 3.62M | -15.05M | 17.95M |
| Change in Payables | 2.61M | 3.1M | 100.57M | -22.55M | -28.29M | 6.76M | -8.06M | -15.7M | 14.91M | 6.37M |
| Cash from Investing | -49.34M | -536.85M | -312.3M | -245.43M | -26.91M | -36.17M | -27.29M | -5.49M | -14.33M | -75.59M |
| Capital Expenditures | -25.72M | -136.94M | -414.19M | -348.81M | -53.08M | -32.21M | -12.13M | -16.96M | -18.86M | -21.68M |
| CapEx % of Revenue | 142.35% | 248.11% | 168.69% | 129.81% | 21.64% | 14.55% | 5.42% | 6.27% | 5.49% | - |
| Acquisitions | -6.92M | -335.57M | 114.35M | 27.88M | 0 | -23.42M | -18.54M | -5.54M | 0 | 590.53K |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -6.75M | -895K | -8.85M | -13.34M | 14.78M | 19.46M | 16K | 12.02M | -956K | -2.46M |
| Cash from Financing | 221.99M | 535.15M | 597.55M | 582.56M | 521.95M | 147.78M | -56.48M | -47.92M | -116K | 5.01M |
| Debt Issued (Net) | 104.59M | 344.82M | 583.74M | -35.91M | -122.92M | -170.83M | - | -85.76M | -805K | 2.34M |
| Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | - | 1000K | 0 | 460.55K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -3.43M | -25.27M | -45.52M | 42.96M | -21.15M | -31.58M | -95.21M | -89K | 689K | 2.22M |
| Net Change in Cash | 159.46M▲ 0% | -83.01M▼ 152.1% | 95.94M▲ 215.6% | -10.55M▼ 111.0% | 259.28M▲ 2558.1% | 16.35M▼ 93.7% | -140.01M▼ 956.3% | -121.5M▲ 13.2% | 1.83M▲ 101.5% | -53.88M▲ 0% |
| Free Cash Flow | -39.1M▲ 0% | -218.61M▼ 459.2% | -606.43M▼ 177.4% | -690.96M▼ 13.9% | -263.66M▲ 61.8% | -142.48M▲ 46.0% | -127.95M▲ 10.2% | -85.46M▲ 33.2% | -2.85M▲ 96.7% | -31.27M▲ 0% |
| FCF Margin % | -216.39% | -396.06% | -246.98% | -257.14% | -107.51% | -64.37% | -57.17% | -31.62% | -0.83% | -8.66% |
| FCF Growth % | -351.61% | -459.17% | -177.4% | -13.94% | 61.84% | 45.96% | 10.2% | 33.21% | 96.66% | -7.69% |
| FCF per Share | -16.81 | -55.66 | -75.69 | -71.41 | -15.59 | -6.63 | -3.96 | -1.67 | -0.05 | -0.05 |
| FCF Conversion (FCF/Net Income) | 1.03x | -1.14x | 0.65x | 0.10x | 0.30x | 0.06x | 0.14x | 0.99x | 10.06x | -0.77x |
| Interest Paid | 471K | 7.07M | 18.05M | 47.9M | 34.16M | 27.73M | - | 11.7M | 6.84M | 6.48M |
| Taxes Paid | - | - | - | - | - | - | - | - | 928K | 0 |
ACB Key Ratios
Aurora Cannabis Inc. (ACB) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -11.5% | 8.07% | -9.84% | -100.72% | -33.43% | -134.35% | -156.52% | -12.33% | 0.26% | 7.15% |
| Return on Invested Capital (ROIC) | -12.02% | -7.98% | -7.33% | -9.55% | -9.48% | -14.22% | -34.74% | -7.18% | 0.71% | 0.71% |
| Gross Margin | 88.87% | 78.84% | 58.01% | -7.42% | -8.79% | 9.59% | 6.61% | 48.64% | 54.65% | 62.72% |
| Net Margin | -71.78% | 130.33% | -119.54% | -1221.68% | -282.82% | -776.02% | -364.88% | -25.65% | 0.46% | 11.24% |
| Debt / Equity | 0.29x | 0.13x | 0.15x | 0.25x | 0.20x | 0.43x | 0.43x | 0.17x | 0.17x | 0.17x |
| Interest Coverage | -8.66x | -8.14x | -8.08x | -6.12x | -4.26x | -3.22x | -5.25x | -3.27x | 0.59x | 6.27x |
| FCF Conversion | 1.03x | -1.14x | 0.65x | 0.10x | 0.30x | 0.06x | 0.14x | 0.99x | 10.06x | -0.77x |
| Revenue Growth | 1155.52% | 205.51% | 344.84% | 9.44% | -8.73% | -9.75% | 1.11% | 20.77% | 27.01% | 12.79% |
ACB Frequently Asked Questions
Aurora Cannabis Inc. (ACB) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Aurora Cannabis Inc. (ACB) reported $361.1M in revenue for fiscal year 2025.
Aurora Cannabis Inc. (ACB) grew revenue by 27.0% over the past year. This is strong growth.
Yes, Aurora Cannabis Inc. (ACB) is profitable, generating $40.6M in net income for fiscal year 2025 (0.5% net margin).
Dividend & Returns
Aurora Cannabis Inc. (ACB) has a return on equity (ROE) of 0.3%. This is below average, suggesting room for improvement.
Aurora Cannabis Inc. (ACB) had negative free cash flow of $31.3M in fiscal year 2025, likely due to heavy capital investments.
Explore More ACB
Aurora Cannabis Inc. (ACB) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates